JDHIY
Get informed when a big investor buys or sells
+ FollowUndervalued by 125.7% based on the discounted cash flow analysis.
| Market cap | $14.87 Billion |
|---|---|
| Enterprise Value | $-4,128,892,549.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.68 |
| Beta | 1.18 |
| Outstanding Shares | 3,177,630,000 |
| P/E Ratio | 16 |
|---|---|
| PEG | 51.76 |
| Price to Sales | 0.11 |
| Price to Book Ratio | 0.25 |
| Enterprise Value to Revenue | 0.68 |
| Enterprise Value to EBIT | 9.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products,...